Biolinerx (BLRX) Posts Q1 Loss of 1c/Share

Biolinerx (NASDAQ: BLRX) reported Q1 EPS of ($0.01), $0.10 better than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Biolinerx (BLRX) click here.

You May Also Be Interested In

• Nvidia pitches Vera CPU to Chinese clients with August delivery target
• Cooper Companies (COO) Reiterated at Buy by Stifel After Earnings Call
• Carvana (CVNA) PT Lowered to $85 at RBC Capital